Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock), and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. It operates through two segments: the United States and International. Within each of these segments, it offers a diversified product portfolio for both livestock and companion animal customers. In addition, its Client Supply Services (CSS) organization provides contract manufacturing services to third parties. It also offers other product categories, such as nutritionals and agribusiness.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Drugs - Generic
- Sub-Industry: Pharmaceuticals
- Exchange: NYSE
- Symbol: ZTS
- CUSIP: 98978V10
- Previous Close: $53.47
- 50 Day Moving Average: $54.35
- 200 Day Moving Average: $51.80
- 52-Week Range: $39.35 - $56.50
- Trailing P/E Ratio: 32.41
- Foreward P/E Ratio: 20.18
- P/E Growth: 1.72
- Market Cap: $26.31B
- Outstanding Shares: 491,964,000
- Beta: 1.07
- Net Margins: 14.10%
- Return on Equity: 72.96%
- Return on Assets: 12.51%
Companies Related to Zoetis:
- Debt-to-Equity Ratio: 2.80%
- Current Ratio: 3.24%
- Quick Ratio: 1.73%
What is Zoetis' stock symbol?
Zoetis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZTS."
How often does Zoetis pay dividends? What is the dividend yield for Zoetis?
Zoetis announced a quarterly dividend on Wednesday, February 15th. Stockholders of record on Thursday, April 6th will be given a dividend of $0.105 per share on Thursday, June 1st. This represents a $0.42 annualized dividend and a dividend yield of 0.79%. The ex-dividend date is Tuesday, April 4th.
Where is Zoetis' stock going? Where will Zoetis' stock price be in 2017?
15 analysts have issued twelve-month price targets for Zoetis' stock. Their forecasts range from $35.00 to $65.00. On average, they expect Zoetis' share price to reach $56.40 in the next year.
When will Zoetis announce their earnings?
Zoetis is scheduled to release their next quarterly earnings announcement on Tuesday, May, 2nd 2017.
What are analysts saying about Zoetis stock?
Here are some recent quotes from research analysts about Zoetis stock:
- Guggenheim analysts commented, "We are raising our PT for ZTS shares after a 4Q beat and a lower than expected FX headwind for '17. The increase in our PT is driven by multiple expansion. We arrive at our new PT by using a DCF analysis. ZTS's solid execution this quarter increases our confidence that it can exceed consensus expectations for '17+ and sustain its 21x forward P/E multiple. Upward earnings revisions could come from margin expansion, M&A, and launches. Therefore, the sell-off today, which we think is motivated by profit taking, is overdone, in our view. We believe the weakness (ZTS down 3% vs. S&P down 0.14%) presents a good buying opportunity for the stock." (2/16/2017)
According to Zacks Investment Research, "Performance of Zoetis’ livestock business has been disappointing. Other headwinds include disease outbreaks and stiff competition in the animal health space. While disease outbreak among animals is a material cause of concern for Zoetis’ livestock products, the company continued to witness a decline in the U.S. sales of swine products in the third quarter of 2016 due to increased competition. Competitive pressures could adversely affect the company’s growth prospects. Pipeline setbacks are another major concern. Particularly, development and regulatory setbacks for late-stage pipeline candidates would be a major disappointment for the company. However, Zoetis’ companion animal business should continue to perform well. Further, its efforts on boosting operational efficiency bode well. Shares of Zoetis have outperformed the industry in the past one year. Estimates have been stable ahead of the company's Q4 results." (1/17/2017)
Who owns Zoetis stock?
Zoetis' stock is owned by many different of institutional and retail investors. Top institutional investors include State Street Corp (4.10%), Marshall Wace LLP (1.68%), Janus Capital Management LLC (1.19%), DSM Capital Partners LLC (0.99%), William Blair Investment Management LLC (0.94%) and Frontier Capital Management Co. LLC (0.45%). Company insiders that own Zoetis stock include Andrew Fenton, Heidi C Chen, Kristin C Peck, Michael B Mccallister, Pershing Square Capital Manage and Roxanne Lagano.
Who sold Zoetis stock? Who is selling Zoetis stock?
Zoetis' stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Calamos Advisors LLC, Renaissance Technologies LLC, Janus Capital Management LLC, William Blair Investment Management LLC, Van ECK Associates Corp, BP PLC and Employees Retirement System of Texas. Company insiders that have sold Zoetis stock in the last year include Andrew Fenton, Heidi C Chen, Kristin C Peck, Pershing Square Capital Manage and Roxanne Lagano.
Who bought Zoetis stock? Who is buying Zoetis stock?
Zoetis' stock was bought by a variety of institutional investors in the last quarter, including DSM Capital Partners LLC, State Street Corp, Asset Management One Co. Ltd., Russell Investments Group Ltd., AMF Pensionsforsakring AB, Frontier Capital Management Co. LLC, Bodenholm Capital AB and Atlanta Capital Management Co. L L C.
How do I buy Zoetis stock?
Shares of Zoetis can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Zoetis stock cost?
One share of Zoetis stock can currently be purchased for approximately $53.47.